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Abstract
Objective—Our aim is to map chromosomal regions that harbor loci that increase susceptibility 
to bipolar disorder.
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Methods—We analyzed 644 bipolar families ascertained by the National Institute of Mental 
Health Human Genetics Initiative for bipolar disorder. The families have been genotyped with 
microsatellite loci spaced every approximately 10 cM or less across the genome. Earlier analyses 
of these pedigrees have been limited to nonparametric (model-free) methods and thus, information 
from unaffected subjects with genotypes was not considered. In this study, we used parametric 
analyses assuming dominant and recessive transmission and specifying a maximum penetrance of 
70%, so that information from unaffecteds could be weighed in the linkage analyses. As in 
previous linkage analyses of these pedigrees, we analyzed three diagnostic categories: model 1 
included only bipolar I and schizoaffective, bipolar cases (1565 patients of whom approximately 
4% were schizoaffective, bipolar); model 2 included all individuals in model 1 plus bipolar II 
patients (1764 total individuals); and model 3 included all individuals in model 2 with the addition 
of patients with recurrent major depressive disorder (2046 total persons).
Results—Assuming dominant inheritance the highest genome-wide pair-wise logarithm of the 
odds (LOD) score was 3.2 with D16S749 using model 2 patients. Multipoint analyses of this 
region yielded a maximum LOD score of 4.91. Under recessive transmission a number of 
chromosome 20 markers were positive and multipoint analyses of the area gave a maximum LOD 
of 3.0 with model 2 cases.
Conclusion—The chromosome 16p and 20 regions have been implicated by some studies and 
the data reported herein provide additional suggestive evidence of bipolar susceptibility genes in 
these regions.
Keywords
bipolar disorder; chromosome 16; chromosome 20; complex disorder; genetics; gene mapping; 
linkage analysis; parametric analysis
Introduction
Bipolar I disorder (BPI), also termed manic-depression, is a severe and often disabling 
neuropsychiatric disorder that afflicts approximately 1% of most populations (Belmaker, 
2004). The direct and indirect costs of this disorder to the American society are tens of 
billions of dollars per year (Kleinman et al., 2003). Approximately 10% of the individuals 
with BPI disorder will die by suicide. Although pivotal neurobiological underpinnings of 
BPI disorder have yet to be unraveled, genetics is of major etiological importance, with an 
estimated heritability of 80% (Merikangas and Low, 2004). Results of some, but not all, 
segregation analyses implicate major loci underlying the disease (Curtis et al., 1993; Pauls et 
al., 1995). Family, twin, adoption and segregation studies, however, indicate that bipolar 
disorder is a complex genetic disease characterized by incomplete penetrance, unknown 
mode of transmission, phenocopies (etiological heterogeneity), and likely genetic 
heterogeneity.
Over 20 genome-wide scans have been reported for bipolar disorder, and the results have 
been recently reviewed (DePaulo, 2004; McQueen et al., 2005) as well as used for two 
meta-analyses (Badner and Gershon, 2002; Segurado et al., 2003). Analyses have implicated 
chromosomes 6q, 8q, 13q, 22q, 18p, 18q, and 22q. One meta-analysis of linkage data from 
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1067 families (n = 5179 individuals) yielded evidence for bipolar loci on 6q [logarithm of 
the odds (LOD) = 4.15] and 8q (LOD = 3.32)(McQueen et al., 2005). Genome-wide linkage 
analyses of uniquely large pedigrees have also implicated a number of chromosomal regions 
including 4p, 4q, 9q, 12q, 21q, and Xq (Blackwood et al., 1996; Adams et al., 1998; Ekholm 
et al., 2003; Green et al., 2005; Shink et al., 2005; Venken et al., 2005). Most of the linkage 
findings in the field, however, have not been thoroughly replicated, most likely because of 
the necessity of large sample sizes for replication (Suarez, 1994). It is, however, clear that 
possible loci for bipolar disorder identified to date account for only a small proportion of 
variance in risk. Although genome-wide association will soon come into play, linkage 
analyses of large bipolar family data sets or uniquely large bipolar pedigrees may still be 
fruitful in mapping additional bipolar loci. Linkage, unlike association, is robust to allelic 
heterogeneity and is not dependent on linkage disequilibrium. Given that both rare and 
common variants likely contribute many if not most complex disorders, both linkage and 
association will be needed to map the full range of bipolar susceptibility loci (Zwick et al., 
2000; Reich and Lander, 2001; Pritchard and Cox, 2002).
In this study we analyzed 644 families ascertained by the National Institute of Mental Health 
Human (NIMH) genetics initiative. These families, currently the largest pedigree series, 
which are freely available to qualified researchers worldwide, are also known in the 
literature as ‘waves 1, 2, 3, and 4 pedigrees’ (Detera-Wadleigh et al., 1997; Edenberg et al., 
1997; Dick et al., 2003; Kassem et al., 2006). The 644 pedigrees contain 1565 individuals 
with BPI disorder or schizoaffective (SA) disorder, bipolar type, 199 persons with bipolar II 
(BPII) disorder, 282 patients with recurrent major depressive disorder (MDD), and 876 
unaffected persons with genotypes. Wave 1, 2, 3, and 4 families have been genotyped, at 
various intervals, with microsatellite loci spaced every approximately 10 cM or less across 
the genome. Linkage studies of these families have been performed in four ‘waves’ 
(McInnes et al., 1996; Detera-Wadleigh et al., 1997; Edenberg et al., 1997; Rice et al., 
1997; Stine et al., 1997; Dick et al., 2003; McInnis et al., 2003; Kassem et al., 2006). 
Implicated regions include 1q, 5q, 6q, 7p, 10p, 16p, 16q, 17q, and 22q. Earlier analyses of 
these pedigrees have been primarily limited to nonparametric or model-free methods and 
thus, unaffected subjects – many of whom presumably carry disease alleles without 
expression of disease – were not considered. In this study, we used parametric analysis, a 
method that allows for the specification of phenocopies, reduced penetrance, and 
transmission models. We chose a model-based approach – dominant and recessive models – 
because simulation studies show that, formulating a genetic model that approximates the 
true inheritance, may have more power than nonparametric analyses (Abreu et al., 1999; 
Durner et al., 1999). As in earlier linkage studies of these pedigrees, three diagnostic models 
were used: model 1 included only BPI or SA, bipolar type cases (1565 cases); model 2 
included model 1 and BPII patients (1764 patients); and model 3 included model 2 and 
recurrent MDD individuals (2046 cases). Of the model 1 cases fewer than 4% were SA, 
bipolar type. Our strategy was to first carry out genome-wide two-point analyses and then 
multipoint analyses in the regions of interest, defined as LODs of 1.5 or greater. Pairwise 
analysis, which considers evidence of linkage at various recombination fractions, can be 
more robust when there are misspecifications in the model, marker location anomalies, 
and/or (undetected) genotyping errors (Risch and Giuffra, 1992; Pal et al., 2001).
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Methods
Family ascertainment
All families were ascertained as part of the NIMH Bipolar Genetics Initiative, which has 
been continuously active for the past 15 years. As part of the four-site collaborative effort 
(Indiana University, Washington University, Johns Hopkins and the NIMH intramural 
program) that existed between 1989 and 1997, 153 multiplex families were ascertained. The 
original four-site consortia families are known as waves 1 and 2. Wave 1 families (n = 97) 
were first ascertained, genotyped, and analyzed (Edenberg et al., 1997). Subsequently, the 
four-site consortia ascertained an additional 56 kindreds that were genotyped and analyzed 
(Dick et al., 2003; Willour et al., 2003; Zandi et al., 2003). In 1998 the project was 
expanded as a 10-site collaborative team (comprising four initial sites plus the University of 
Pennsylvania, University of Iowa, University of Chicago, University of California–San 
Diego, University of California–San Francisco, University of Michigan) to ascertain at least 
500 families containing at least two siblings with either BPI or SA-bipolar type (Dick et al., 
2003; Kassem et al., 2006) during a 4-year period from 1998 to 2002; it exceeded the 
original aims of the grant and collected 546 pedigrees. The 10-site collaborative families are 
denoted as waves 3 and 4. Wave 3 families (n = 250) were ascertained, genotyped, and 
analyzed (Dick et al., 2003) before wave 4 families (n = 309) (Kassem et al., 2006). In all, 
699 families were ascertained, and none of the waves contained overlapping pedigrees. 
Some of the ascertained families were eliminated from genotyping or final linkage analyses 
because of lack of informativeness for linkage and mispaternity. Over 95% of the pedigrees 
are European Caucasian.
Detailed procedures for ascertainment and diagnoses have been reported earlier (Edenberg et 
al., 1997; Dick et al., 2002). In brief, the Diagnostic Interview for Genetic Studies (DIGS) 
was used to interview patients (Nurnberger et al., 1994). Additional diagnostic information 
was collected from multiple family informants using the Family Interview for Genetic 
Studies and from medical records when available. Diagnoses was assigned by two non-
interviewing clinicians, who reviewed the DIGS, Family Interview for Genetic Studies, and 
medical records in a best estimate procedure (Leckman et al., 1982). Diagnostic 
disagreements were resolved by a third, independent reviewer if needed (less than 2% of 
cases). Diagnostic and Statistical Manual of Mental Disorders-III-R criteria were used for 
BPI and SA, bipolar. Research diagnostic criteria were used for BPII with the additional 
requirement that patients also had to have recurrent episodes of major depression. Research 
diagnostic criteria were used for Unipolar Depression, Recurrent. Although DSM-IV criteria 
were published in 1990, the initial diagnostic criteria were used during all four waves of the 
study to maximize diagnostic consistency.
All of this material, including DNA and cell lines, best estimate final diagnoses, detailed 
clinical data from the DIGS, pedigree relationship information, and genotypic data from a 
complete genomic survey, is available to qualified investigators through application to the 
Center for Genetic Studies – www.nimhgenetics.org.
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Genotyping
Waves 1, 2, 3, and 4 families were genotyped separately over several years. Wave 1 and 2 
families (23% of the pedigrees) were genotyped by the University sites and NIMH 
intramural program using microsatellite loci derived from early marker maps. Wave 3 and 4 
families (77% of the kindreds) were genotyped at the Center for Inherited Disease Research 
in two separate samples. The genotype data waves 1, 2, 3, and 4 were cleaned and combined 
in a project coordinated by Melvin McInnis and Peter Zandi at Johns Hopkins University 
(Goes et al., 2007). A number of methods that have been described in detail earlier were 
used to check the genotype data for quality control. The programs UNKNOWN and 
PEDCHECK were used to check for inheritance errors (Lathrop et al., 1984, O’Connell and 
Weeks, 1998). The PREST software (http://linkage.rockefeller.edu/soft/) was used to check 
for unlikely relationships (Sun et al., 2002). Finally, the output from CRIMAP (http://
linkage.rockefeller.edu/soft/) was used to check for unlikely double recombinants (Lander 
and Green, 1987). Identified errors that could not be resolved were removed from the data 
set. A common genetic map was constructed for the markers using the deCode map as a 
framework. For microsatellite loci not on the deCode map their relative physical distances 
were used to interpolate them into the genetic map. Altogether 685 microsatellite loci were 
genotyped, 366 of which were genotyped in more than one wave (Goes et al., 2007).
Diagnostic models for linkage
Three diagnostic models were used: model 1 included only BPI and SA, bipolar type cases, 
model 2 included model 1 and BPII patients, and model 3 included model 2 individuals and 
recurrent MDD patients.
Linkage analyses
Parametric analyses were carried using the FASTLINK 4.1 modifications to the LINKAGE 
(http://linkage.rockefeller.edu/soft/) software program. We chose a model-based approach 
(dominant and recessive models) because simulation studies show formulating a genetic 
model that approximates the true inheritance may have more power than nonparametric 
analyses (Abreu et al., 1999; Durner et al., 1999). With parametric analyses one can weigh 
evidence of linkage that some unaffected individuals harbor the disease allele, but did not 
express illness by using penetrance functions. Family and twin studies indicate that many, if 
not most, susceptibility alleles for bipolar disorder have reduced penetrance. For the 
dominant model, we assumed a disease allele frequency of 0.01, a penetrance of 0.7 for the 
heterozygote and homozygote and a penetrance of 0.001 for the normal allele. For the 
recessive model we assumed a disease allele frequency of 0.10, a penetrance of 0.7 for the 
homozygote and a penetrance of 0.001 for the normal allele. These parameters are 
conservative (e.g. penetrance should not be overestimated) and approximate those in the 
literature for parametric analyses. Genome-wide two-point calculations were first carried out 
using the MLINK subroutine. Multipoint analyses were then performed in regions of 
interest, defined as an area yielding a two-point LOD score of 1.5 or higher.
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Linkage results
Pairwise
A summary of the genome-wide pairwise analyses is presented in Table 1. Only scores 
above 1.5 are presented. D16S748, located 22.65 cM from pter, yielded the highest genome-
wide LOD score, 3.29 (θ = 0.3) assuming dominant transmission and using model 2 cases. 
Flanking markers also produced positive scores using model 2 cases: D16S749, LOD 1.57 at 
θ = 0.2 (Tables 1 and 2). Evidence of linkage decreased under model 3, which included 282 
cases of recurrent unipolar depression: (D16S748, max LOD of 1.97 at 0.3 θ). One 
explanation for this is that recurrent unipolar disorder is more etiologically and genetically 
heterogeneous and thus, having these cases in the linkage analysis would include more 
phenocopies. The second highest genome-wide pairwise LOD score was obtained with 
D4S2390 using model 1 cases only and assuming dominant transmission (LOD 2.01 at 0.1 
θ). D4S2390 is located 208.07cM from the pter. Under recessive transmission and using 
model 1 cases D4S2390 yielded a LOD score of 1.67 (0.2 θ).
Three markers on chromosome 20 produced positive scores assuming recessive transmission 
(Tables 1 and 3). D20S601 (50.81 cM from the pter) generated a LOD score of 1.90 using 
model 3 cases. Using model 2 cases D20S473 (9.53 from the pter) yielded a LOD score of 
1.71 at D20S162 (24.7 cM from the pter) produced a LOD score of 1.60.
Multipoint
Multipoint linkage analyses were carried in areas that generated two-point scores above 1.5. 
The most significant multipoint linkage signals occurred on chromosome 16 (dominant 
transmission) and 20 (recessive inheritance) with the model 2 phenotype (Figs 1 and 2). For 
chromosome 16 the highest multipoint score was 4.91 derived using three contiguous 
chromosome 16 loci: D16S748, D16S2619, and D16S3103 (Fig. 1). Three-point analyses 
yielded maximum LODs of four or greater (Fig. 1). Assuming recessive inheritance and 
using model 2 cases chromosome 20 multipoint with D20S473 and D20S604 produced a 
maximum LOD of just over 3.0. Although chromosome 4 had a suggestive two-point LOD 
score of 2.01 at loci D4s2390, multipoint linkage analysis on chromosome 4 did not 
generate an increase in the maximum LOD score at this loci, and the maximum multipoint 
LOD generated in these analyses was 1.56 using D4s3335 and D4s2390.
Discussion
Genome-wide parametric analyses were carried out between bipolar disorder phenotypes 
using 644 families and 685 microsatellite loci. Earlier studies of the 644 pedigrees have been 
primarily limited to nonparametric analyses and thus, information from unaffecteds was not 
considered for most analyses. Although Avramopoulos et al. (2004) used parametric 
methods, only 56 pedigrees were analyzed. The strategy for this study was to first carry out 
genome-wide parametric two-point analyses and then multipoint analyses in regions 
yielding LODs of 1.5 or greater. Two-point analyses, which consider evidence for linkage at 
various recombination fractions, can be more robust when there are misspecifications in the 
model, marker location anomalies, and/or (undetected) genotyping errors. Three 
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interdependent definitions of illness were used: model 1 included BPI cases and SA disorder 
(bipolar type) cases; model 2 consisted of individuals with model 1 phenotypes and BPII 
disorder; and model 3 comprised model 2 cases and recurrent major depression patients. In 
this study, both dominant and recessive transmission models were implemented using a 
maximum penetrance of 70%. These parameters are conservative (e.g., penetrance should 
not be overestimated) and approximate those in the literature for parametric analyses. The 
LOD scores were not corrected for multiple testing given that the genetic models are 
interdependent and thus, not totally independent tests. Thus, the linkage results should be 
interpreted with caution.
Genome-wide, the most positive results were on chromosomes 16 and 20 using model 2 
cases (Tables 1–3; Figs 1 and 2). D16S748 yielded the highest two-point LOD score (3.2) 
assuming dominant inheritance (Table 1). D16S748 is located approximately 23cM from 16 
pter. Flanking markers also gave positive pairwise LOD scores (Table 2). A series of three-
point and four-point analyses were then carried out. A multipoint analysis of three fixed 
chromosome 16 markers (D16S748, D16S2619 at 28.30 cM from the pter, and D16s3103 at 
37.97 cM from the pter) yielded the highest maximum LOD score 4.91 (Fig. 1). Three-point 
analyses with various chromosome 16 markers yielded LODs of approximately 3.2–4 (Fig. 
1). These findings reinforce the results of analyses carried out before on the initial waves of 
the NIMH genetics initiative. Edenberg et al. (1997) analyzed 97 wave 1 NIMH bipolar 
kindred sib pairs that yielded positive scores (P = 0.006) between the model 2 phenotype 
and D16s2610 (28cM from 16 pter). Dick et al. (2002) carried out nonparametric linkage 
analyses of 97 wave 1 and 56 wave 2 pedigrees and reported a LOD score of 2.8 with 
D16s2619 (28cM from the 16 pter) using model 3 cases. Chromosome 16p has also been 
implicated in studies of other samples. Ewald et al. (1995) studied two Danish bipolar 
pedigrees and reported a LOD score of 2.5 with D16S510 under the assumption of recessive 
transmission and using all phenotypic definitions of bipolar illness (BPI, BPII, and recurrent 
major depression). D16S510 maps approximately 10cM from 16 pter. In one large Costa 
Rica family segregating bipolar disorder McInnes et al. (1996) found a LOD of 1.46 with 
D16S521 assuming dominant inheritance and using BPI cases only. D16S521 localizes to 
the telomeric end of 16p (about 1 cM from 16 pter). In the Finnish population Ekholm et al. 
(2003) ascertained 40 pedigrees with bipolar disorder and reported a three-point LOD of 2.7 
between D16S769 (41.96cM from the 16 pter), and D16S3093 (37.97cM from 16 pter) 
using cases equivalent to model 1. Finally, Kassem et al. (2006) recently examined ‘polarity 
at onset’ using 507 waves 3 and 4 NIMH Genetics Initiative pedigrees. Linkage analyses 
restricted to those patients displaying mania at onset yielded a maximum multipoint LOD of 
4.5 with D16S748, the marker that also yielded the highest LOD score in this study. It is 
likely that both studies have detected the same signal as waves 3 and 4 pedigrees comprise 
77% of the kindreds studied herein. In a subsequent analysis, McMahon and colleagues 
carried out linkage analyses of all four waves using LODPAL, a multipoint affected relative 
pair program implemented in the SAGE (http://linkage.rockefeller.edu/soft/) package 
(version 4.4) that is capable of incorporating clinical covariates to adjust the relative risks 
associated with sharing identity by descent alleles, and yielded a Lodpal score of 5.1 with 
mania at onset and as a covariate (Francis McMahon personal communication to William 
Byerley).
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The next most positive region was chromosome 20. Using model 2 cases D20S473 (9.53 cM 
from the pter) yielded a LOD score of 1.71 and D20S162 (30.34cM from the pter) produced 
a LOD score of 1.60. D20S601 (50.81 cM from the pter) produce a LOD score of 1.90 using 
model 3 cases. Using model 2 cases multipoint analyses with the D20S473, D20s482 and 
D20s162 marker loci produced a maximum LOD of just over 3.0. Chromosome 20 has been 
implicated by two published studies. Radhakrishna et al. (2001) found a multipoint LOD 
score of 4.35 between bipolar disorder and chromosome 20 markers assuming dominant 
transmission. The chromosome 20 markers D20s482 and D20s162 map 13.21 and 30.34 cM 
from the pter. Using wave 1 and 2 families Willour et al. (2003) reported a LOD of 1.82 
using model 3 cases and assuming recessive transmission.
Other pairwise scores greater than 1.5 included D1S462 (about 97 cM from the pter), 
D4S2390 (about 208.07 from the pter), D6S495 (about 150cM from the pter), D8S1771 
(about 50 cm from the pter), D11S3163 (about 0cM from the pter), and D12S395 (about 137 
cm from the pter). Many of these regions have been implicated by other studies 
(Avramopoulos et al., 2004; Green et al., 2005; McQueen et al., 2005; Shink et al., 2005; Le 
Hellard et al., 2007). Multipoint analyses, however, did not increase evidence of linkage in 
these regions (data not shown).
Although genome wide linkage analysis has been the major method for mapping disease loci 
for over two decades, genome wide association (GWA) is now being used for gene 
mapping. Interestingly, two published analyses of these studies have implicated regions on 
chromosomal regions 16p and 20p in bipolar disorder. The first GWA study of bipolar 
disorder used 461 unrelated probands drawn from the NIMH genetics initiative, and 563 
matched controls, and identified 88 SNPs with association signals and small effect sizes, that 
were detected in both the initial sample as well as the replicate sample of 772 bipolar I 
patients recruited from consecutive hospital admissions in Germany. Three SNPs were 
identified on chromosome 16, rs1818290 and rs7204975 at 16p13.2, and rs10500336 at 
16p13.3. The SNP rs4813030 on chromosomal region 20p13 was also identified in both the 
initial and replication samples in this study (Baum et al., 2008).
A recently completed GWA funded by the Wellcome Trust (http://www.perlegen.com/
index.htm?newsroom/pr/2005/2005_10_05_Wellcome_Trust_Affy_Press_Release.htm) 
examined seven major diseases including bipolar disorder, with 2000 affected subjects for 
each disorder and 3000 controls. Results from this study identified the chromosomal region 
16p12 at 23.3–23.62Mb as a region of strong association for bipolar disorder with a P value 
of 6.29×10−8. The region on chromosme 20p13 from 3.70 to 3.73Mb was also identified as 
showing moderate evidence for association in bipolar disorder, with a genotypic P value of 
6.71×10−6 (The Wellcome Trust Case Control Consortium, 2007).
At least one other large GWA funded by the Pritzker Foundation (http://
www.pritzkerneuropsych.org/news/news.aspx) is underway. Although GWA may be more 
powerful for mapping common variants, underlying disease linkage analysis does not 
depend on the presence of linkage disequilibrium and is more robust for detecting rare 
variants, especially loci having a wide range of allelic heterogeneity. Of note, many 
Mendelian disorders average ~10 alleles at one locus. As a result, both linkage and 
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association will likely be needed to map the full range of susceptibility loci for complex 
traits as both common and rare variants contribute to disease liability.
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Fig 1. 
Chromosome 16 maximum multipoint logarithm of the odds scores using a bipolar II – 
dominant transmission model.
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Fig 2. 
Chromosome 20 maximum multipoint logarithm of the odds scores using a bipolar II – 
recessive transmission model.
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